Pharmaceutical composition of a tachykinin receptor antagonist

The present invention is directed to novel pharmaceutical compositions of the compound 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine. The pharmaceutical compositions of this invention useful in the treatment or preventio...

Full description

Saved in:
Bibliographic Details
Main Authors Bosch, H. William, Liversidge, Elaine, Shelukar, Suhas D, Thompson, Karen C
Format Patent
LanguageEnglish
Published 04.09.2012
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to novel pharmaceutical compositions of the compound 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine. The pharmaceutical compositions of this invention useful in the treatment or prevention of disorders such as psychiatric disorders including depression and anxiety, inflammatory diseases and emesis.